(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GEROADX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GEROADX

ST13

US500000079400440

Class

1, 5, 10, 44

Filing

79400440

Registration

8105539

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

08/13/2026

Trademark type

Combined

Nice classes

1, 5, 10, 44

Filing date

04/10/2024

Registration date

01/20/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/20/2026

Last transaction

08/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

ES

Examiner

CORNWELL, ANDREA B

Law office

M60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "GEROADX" with a chevron on the right side of the letter "X".

Holders and representatives

Holders

G. S. (pessoa física)

Representatives

Ramón Andres Urteaga PatentXL Law Firm

Technical classification

Nice Classes

Class 1Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations for scientific use; diagnostic preparations for use in research laboratories; diagnostic substancesother than those for medical usefor scientific research in the field of neurodegenerative diseases using the salivary biomarker lactoferrin; diagnostic kits comprising specimen receptors in the nature of microplates coated with anti-lactoferrin antibodies and diagnostic reagents for analyzing selected bacteria for purposes of quantifying salivary lactoferrin for scientific research purposes; diagnostic reagentsexcept for medical or veterinary use

Class 5

Diagnostic preparations for medical use; diagnostic substances for medical use; medical diagnostic test strips for saliva analysis for the early detection of Alzheimer's Disease and Mild Cognitive Impairment associated with Alzheimer's Disease; diagnostic agents for medical use; diagnostic products for medical usemedical diagnostic reagents and immunoassay kits comprising diagnostic agentspreparations and substances for in vitro quantification of salivary lactoferrin; diagnostic testing materials for medical usediagnostic test reagents and antibody-coated microplates for in vitro testing for medical use; diagnostic preparations for medical use in medical laboratories; products for medical diagnosticsmedical diagnostic reagentsimmunoassay kits comprising diagnostic agentspreparations and substancesdiagnostic preparations for the in vitro detection of the salivary biomarker lactoferrinassociated with Alzheimer's Disease and Mild Cognitive Impairment associated with Alzheimer's Disease; diagnostic reagents for medical use; chemical diagnostic reagents for medical use

Class 10

Automatic saliva biomarker analyzers for medical diagnostic purposes; medical immunochemical diagnostic apparatus for medical use; detector apparatus for medical use in diagnosis namelydiagnostic apparatus for the detection and quantification of salivary lactoferrin as a biomarker associated with Alzheimer's Disease; diagnostic apparatus for measuring for medical useimmunochemical diagnostic testing apparatus for measuring salivary lactoferrin levels as an aid in the early detection of Alzheimer's Disease

Class 44

Medical analyses for the diagnosis and treatment of people; medical diagnostic servicesincluding medical diagnostic testing and analysis; medical services for the diagnosis of diseases in the human body

Publications

History of USPTO decisions and trademark events.

38 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/13/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/24/2026

FIMP

FINAL DISPOSITION PROCESSED

07/24/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/20/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/20/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/20/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/08/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/24/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/24/2025

GPNX

NOTIFICATION PROCESSED BY IB

12/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/02/2025

PUBO

PUBLISHED FOR OPPOSITION

12/02/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/26/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/26/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/03/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

11/03/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/03/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

11/03/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/31/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/31/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/01/2025

GNFR

FINAL REFUSAL E-MAILED

05/01/2025

CNFR

FINAL REFUSAL WRITTEN

05/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/05/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/05/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/05/2025

RFNT

REFUSAL PROCESSED BY IB

11/23/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/07/2024

RFRR

REFUSAL PROCESSED BY MPU

11/07/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/31/2024

CNRT

NON-FINAL ACTION WRITTEN

10/30/2024

DOCK

ASSIGNED TO EXAMINER

10/23/2024

MAFR

APPLICATION FILING RECEIPT MAILED

07/26/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/26/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/25/2024

Continuous trademark protection

Get notified about every new filing that threatens GEROADX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.